Title : The Novel C-terminal Truncated 90-kDa Isoform of Topoisomerase IIα (TOP2α/90) Is a Determinant of Etoposide Resistance in K562 Leukemia Cells via Heterodimerization with the TOP2α/170 Isoform.

Pub. Date : 2018 May

PMID : 29514855






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The Novel C-terminal Truncated 90-kDa Isoform of Topoisomerase IIalpha (TOP2alpha/90) Is a Determinant of Etoposide Resistance in K562 Leukemia Cells via Heterodimerization with the TOP2alpha/170 Isoform. Etoposide DNA topoisomerase II alpha Homo sapiens
2 The Novel C-terminal Truncated 90-kDa Isoform of Topoisomerase IIalpha (TOP2alpha/90) Is a Determinant of Etoposide Resistance in K562 Leukemia Cells via Heterodimerization with the TOP2alpha/170 Isoform. Etoposide DNA topoisomerase II alpha Homo sapiens
3 We previously characterized a C-terminally truncated isoform (TOP2alpha/90), detectable in human leukemia K562 cells but more abundantly expressed in a clonal subline, K/VP.5, with acquired resistance to the anticancer agent etoposide. Etoposide DNA topoisomerase II alpha Homo sapiens
4 Forced expression of TOP2alpha/90 in K562 cells suppressed, whereas siRNA-mediated knockdown of TOP2alpha/90 in K/VP.5 cells enhanced, etoposide-mediated DNA strand breaks compared with similarly treated cells transfected with empty vector or control siRNAs, respectively. Etoposide DNA topoisomerase II alpha Homo sapiens
5 In addition, forced expression of TOP2alpha/90 in K562 cells inhibited etoposide cytotoxicity assessed by clonogenic assays. Etoposide DNA topoisomerase II alpha Homo sapiens